Valence 標誌
熱門
登入

加入到自選清單

Clover Health Investments...

NasdaqGS: CLOV · 即時價格 · USD
4.27
-0.33 (-7.17%)
收盤時： Aug 18, 2026, 3:59 PM
4.28
+0.23%
盤後: 7:54 PM

Clover Health Investments Corp. (CLOV) Stock Price, Analysis & Data

-7.17%
買價n/a
市值2.27B
營收 (ttm)2.48B
淨利（ttm）-18.36M
貝塔2.48
EPS (ttm)-0.05
本益比（ttm）n/a
正向 PE28.47
P/B (ttm)6.01
P/S (ttm)0.92
Earnings DateNov 4, 2025
賣價n/a
成交量5,308,805
20 日平均成交量6,867,462
打開4.57
上一頁關閉4.60
日間範圍4.15 - 4.57
52 週範圍1.58 - 5.59
分析師Buy
目標價5 (17.10%)
股利n/a
Ex-股利日期n/a

關於CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware....

[閱讀更多]
工業 Healthcare Plans
部門 Healthcare
IPO 日期 Jun 12, 2020
員工 724
證券交易所 NasdaqGS
股票代號 CLOV
網站 https://www.cloverhealth.com
完整的公司簡介

財務表現

Clover Health Investments 在 2025 年的營收為 1.92B，較前一年的 1.37B 增加 40.34%。 淨利為 -85.55M，較前期增加 98.91%。

財務報表

分析師預測

根據3 分析師評等，CLOV股票的平均評等為「Buy」。 12個月股價預測為5，與最新價格相比為上漲空間的17.1%。

股票預測

獲利驚喜

Clover Health Investments 已於 Aug 5, 2026 公布季度財報：
  • 營收的 $743.17M 錯過估計 $0, 與 55.60% YoY 成長.
  • EPS 的 0.07 超出估計 0.02, 與 40.00% YoY 成長.

    • 下次財報發布

    Clover Health Investments Corp. 定於發布財報 Nov 4, 2025, 收盤後。
    分析師預估營收 ... 升級
    news image

    4 天 前 · Simply Wall St.

    Is Clover Health Investments (CLOV) Fairly Valued After A 228% Run?

    Clover Health Investments has delivered a very strong 227.7% return over the past 3 years, yet the share price around US$4.49 now lines up with valuation checks that suggest the stock no longer looks ...

    news image

    4 天 前 · Simply Wall St.

    Does Clover’s Profit Turn and Raised 2026 Guidance Reshape the Bull Case for CLOV?

    Clover Health Investments, Corp. has already reported its second-quarter 2026 results, posting revenue of US$743.17 million versus US$477.62 million a year earlier and moving from a net loss of US$10....

    news image

    4 天 前 · StockStory

    The 5 Most Interesting Analyst Questions From Clover Health’s Q2 Earnings Call

    Clover Health’s second quarter results were met with a positive market reaction, driven by strong Medicare Advantage membership growth and improved profitability. Management credited the quarter’s per...

    news image

    5 天 前 · Motley Fool

    Clover Health (CLOV) Q2 2026 Earnings Call Transcript

    Medicare Advantage membership surged 48% as profitability improved sharply.

    news image

    1 週 前 · MarketBeat

    Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth

    Clover Health Investments (NASDAQ:CLOV) is positioning its Medicare Advantage model around earlier identification and treatment of chronic conditions, Interim Chief Financial Officer Clay Thornton sai...

    第 1 頁，共 2 頁